Saudi Arabia Blood Bags Market, By Product Type (Single Blood Bag, Double Blood Bag, Triple Blood Bag, Quadruple Blood Bag, Penta Blood Bag), By Type (Collection Bag, Transfer Bag), By Volume (100ml, 150ml, 250ml, 300ml, 350ml, 400ml, 450ml, 500ml), By Material (PVC, PET, Others), By End User (Hospitals & Clinics, Ambulatory Surgical Centre, Blood Banks, Others) By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

The Saudi Arabia Blood Bags market was valued at USD 11.74 Million in 2024 and is expected to reach USD 16.02 Million by 2030 with a CAGR of 5.28% through forecast period. The Saudi Arabia blood bags market represents a specialized yet essential segment of the country’s broader healthcare and medical devices sector. It is primarily driven by the increasing demand for safe, reliable, and efficient systems for blood collection, storage, and transfusion. As the Kingdom accelerates its investment in healthcare infrastructure under the Vision 2030 reform agenda, the consumption of medical disposables, particularly blood bags is witnessing steady growth. This upward trajectory is further reinforced by the rising number of surgical interventions, trauma-related emergencies, and chronic hematologic conditions such as thalassemia and sickle cell anemia, which require regular transfusions. Additionally, maternal health complications and expanding public health programs continue to contribute significantly to the increasing utilization of blood and blood components.

Key Market Drivers

Growing Prevalence of Blood-Related Diseases

the most significant demand-side drivers of the Saudi Arabia blood bags market is the increasing prevalence of blood-related diseases, both genetic and acquired. According to 2020 data from the Global Cancer Observatory, Saudi Arabia recorded 1,676 newly diagnosed cases of leukemia, underscoring the country’s growing burden of hematologic malignancies. In the same year, non-Hodgkin’s lymphoma accounted for 1,698 cases, while Hodgkin’s lymphoma and multiple myeloma contributed to 687 and 265 cases, respectively. These medical conditions, which often require frequent and sustained transfusion therapy, are directly contributing to the rising consumption of blood bags across hospitals, blood banks, and specialty care centers throughout the Kingdom. Saudi Arabia reports relatively high rates of hereditary blood disorders, particularly sickle cell anemia and thalassemia, which are prevalent in certain regions due to patterns of consanguinity and genetic predisposition. These conditions necessitate regular blood transfusions as part of long-term disease management. Thalassemia patients often require monthly transfusions to maintain hemoglobin levels and prevent complications. Sickle cell patients frequently need transfusions during vaso-occlusive crises or to prevent stroke and organ damage. In Saudi Arabia, approximately 4.2% of the population carries the sickle cell trait, while 0.26% are diagnosed with sickle cell disease. The condition is highly concentrated in the Eastern Province, where the prevalence is significantly higher than around 17% of the population are gene carriers, and 1.2% live with the disease. This regional disparity places a disproportionate demand on healthcare resources, particularly for specialized transfusion services, driving localized growth in the consumption of blood bags and related transfusion products. This chronic and ongoing need creates a recurring demand for blood bags, particularly triple and quadruple bags used for component separation, enabling targeted treatment with red blood cells or plasma.

Diseases such as leukemia, lymphoma, and myelodysplastic syndromes are seeing increased incidence due to better diagnostic capabilities and greater awareness. Treatment protocols for these cancers often include chemotherapy, which can suppress bone marrow function, leading to anemia and thrombocytopenia—conditions that require transfusions of red blood cells and platelets. Additionally, chronic kidney disease (CKD), which is on the rise due to lifestyle-related illnesses such as diabetes and hypertension, often necessitates transfusions, especially in advanced stages when patients undergo dialysis. Saudi Arabia continues to experience maternal health issues that result in postpartum hemorrhage, a leading cause of maternal morbidity. Similarly, neonatal and pediatric patients with hemolytic disease or congenital anemia also require transfusions. These scenarios create consistent demand for sterile, safe, and traceable blood bags, particularly small-volume pediatric blood bags in specialized care settings. As the management of blood disorders evolves, there is a shift from whole blood transfusions to component therapy, where specific components (RBCs, plasma, platelets) are administered based on patient needs. This transition significantly increases the use of multi-bag blood collection systems, as blood drawn from a single donor can now be fractionated for use across multiple patients, maximizing utility and reducing wastage. This approach requires high-quality, compartmentalized blood bag systems that maintain the integrity and sterility of individual components, further fueling demand for technologically advanced products. The Ministry of Health, along with other national healthcare agencies, has prioritized the early detection and management of hereditary and chronic blood diseases through screening programs and specialized care centers. This institutional emphasis increases transfusion volumes across the public health system and, in turn, stimulates procurement of consumables such as blood bags.

Expansion of Healthcare Infrastructure under Vision 2030

Under Vision 2030, the Kingdom is actively expanding its hospital network, including the construction of new general hospitals, trauma centers, and specialty care facilities. This infrastructure growth has led to a significant increase in capacity for surgical, emergency, and oncology care, all of which depend heavily on blood transfusions. As a result, the volume requirements for blood collection, storage, and component separation bags have surged in tandem with institutional demand. Additionally, public-private partnership (PPP) models encouraged under Vision 2030 are leading to increased procurement activity in the private healthcare sector, further accelerating demand for sterile, high-quality blood bag systems. As part of its broader healthcare transformation under Vision 2030, Saudi Arabia is pursuing a strategic overhaul aimed at enhancing care quality, strengthening public health outcomes, and building a more resilient and technology-driven healthcare system. A key milestone in this initiative is the launch of the SEHA Virtual Hospital in 2022 the largest virtual healthcare facility in the world. This platform integrates over 150 hospitals across the Kingdom, providing access to more than 30 specialized medical services, and significantly expanding the reach and efficiency of clinical expertise through centralized, digitally enabled care delivery.

Vision 2030 has also prioritized the decentralization of healthcare services, resulting in the establishment and modernization of regional blood banks and transfusion centers. These facilities require reliable supply chains for blood bag systems that support efficient blood collection, component separation, and traceability. This structural expansion not only broadens the market base for suppliers but also elevates the standards for product quality and regulatory compliance. The Kingdom's healthcare transformation includes a strong emphasis on digital health, automation, and global best practices. This has driven a shift from conventional whole blood transfusion to component therapy, which relies on multi-compartment blood bags (e.g., double, triple, and quadruple bags). Hospitals and clinics are increasingly seeking technologically advanced blood bag systems that support efficient processing, minimize contamination risks, and integrate with digital tracking systems creating demand for value-added solutions within the blood bags segment. The expansion of operating theaters, ICUs, and emergency departments has led to a rise in planned and unplanned surgical procedures, which are among the largest consumers of transfusion products. With a growing pool of patients undergoing transplants, cardiovascular procedures, and trauma care, hospitals require a consistent and high-volume supply of blood bags, further solidifying the product's position as a procurement priority.

Download Free Sample Report

Key Market Challenges

Supply Chain Disruptions and Import Dependency

Saudi Arabia remains heavily reliant on imported medical consumables, including blood bags, which exposes the market to global supply chain vulnerabilities. Disruptions caused by geopolitical tensions, logistics constraints, or raw material shortages can result in delays in product availability and inconsistent inventory levels at healthcare facilities. These issues are particularly critical for blood bags, which are essential for life-saving procedures and cannot afford prolonged supply gaps.

Customs clearance procedures, import licensing complexities, and fluctuating foreign exchange rates add operational inefficiencies and increase procurement costs for healthcare institutions. Although Vision 2030 encourages localization, the domestic manufacturing base for advanced, multi-compartment blood bags remains underdeveloped, further limiting supply flexibility and responsiveness.

Limited Public Awareness and Inconsistent Blood Donation Rates

One of the persistent systemic challenges in the Kingdom is the lack of consistent voluntary blood donation, which affects the stability of the national blood supply chain. While the Ministry of Health conducts awareness campaigns, cultural hesitancies, misconceptions, and a lack of routine donor engagement hinder participation levels, especially outside of urban centers.

This unpredictability in blood collection volumes translates into irregular demand cycles for blood bags, making it difficult for suppliers to forecast accurately and optimize distribution. It also places added pressure on hospitals to manage inventories efficiently, often resulting in overstocking or stockouts both of which impact cost and service delivery.

Key Market Trends

Transition Toward Blood Component Therapy and Precision Transfusion

A key clinical trend gaining momentum is the increased preference for blood component therapy over whole blood transfusion. Hospitals and transfusion centers are rapidly moving toward targeted treatment using red blood cells, plasma, or platelets, based on patient-specific requirements. This precision-driven approach not only improves therapeutic outcomes but also maximizes the utility of each blood unit.

As a result, there is rising demand for multi-compartment blood bags such as triple and quadruple bags that enable efficient separation and storage of individual blood components. This shift is influencing procurement preferences among hospitals and pushing manufacturers to develop more sophisticated blood bag systems that can support component therapy with enhanced sterility, durability, and traceability.

Integration of Digital Tracking and RFID-Enabled Blood Bag Systems

Another emerging trend is the digitization of transfusion workflows, including the tracking and traceability of blood bags from collection to transfusion. Increasingly, healthcare providers in Saudi Arabia are adopting RFID (Radio-Frequency Identification) and barcoding technologies integrated into blood bags and inventory systems. This trend is driven by the need to: Minimize human error, reduce wastage due to expired or mishandled units, enhance traceability and compliance with SFDA standards, Improve inventory visibility across hospitals and blood banks.

This evolution is creating a new subsegment for smart blood bags, and suppliers offering digitally integrated solutions are likely to gain competitive advantage. It also opens the door for partnerships between blood bag manufacturers and healthcare IT vendors to develop end-to-end transfusion management systems.

Segmental Insights

Product Type Insights

Based on the category of Product Type, the Triple Blood Bag segment dominated the Saudi Arabia Blood Bags Market in 2024. The Triple Blood Bag segment currently holds the largest market share in Saudi Arabia. This dominance is attributed to its widespread use in routine blood donation and hospital transfusion centers, where blood is processed into red blood cells, plasma, and buffy coat (or platelets). This configuration offers the optimal balance between cost-efficiency and clinical utility, making it the preferred choice for most government-run and private healthcare facilities.

Alignment with component separation standards set by the Ministry of Health and the Saudi Central Blood Bank. High compatibility with existing centrifugation and storage infrastructure in hospitals. Growing prevalence of conditions like anemia, thalassemia, sickle cell disease, and cancer, all of which require tailored component therapy rather than whole blood. As hospitals transition from single-unit whole blood transfusions to targeted therapies, the triple blood bag offers an efficient and scalable solution, resulting in sustained procurement volume and institutional preference. These factors are expected to drive the growth of this segment.

Material Insights

Based on the category of Material, the PVC segment emerged as the fastest growing segment in the Saudi Arabia Blood Bags Market in 2024. The key accelerators of PVC’s growth in Saudi Arabia is its cost-effectiveness, especially when compared to alternative materials like polyolefin or EVA (ethylene vinyl acetate). For a healthcare system undergoing large-scale modernization under Vision 2030, PVC offers a reliable, scalable, and economically viable solution for government and private sector procurement. Hospitals and blood banks engaged in bulk purchasing tenders favor PVC-based systems for their ability to meet both quality and budgetary requirements. This is particularly true in the public healthcare sector, where efficiency in procurement cycles is a top priority.

PVC blood bags are widely approved by international regulatory bodies and are compatible with the Saudi Food and Drug Authority (SFDA) standards, making them a default choice for many vendors entering the market. The availability of CE-marked and FDA-approved PVC blood bags also enables a smoother registration process, further accelerating market entry and adoption. This regulatory standardization ensures product uniformity, reduces the administrative burden on healthcare institutions, and facilitates interoperability with existing centrifuges, sealers, and refrigeration equipment. While traditional PVC bags have faced scrutiny over DEHP plasticizers due to potential health concerns, manufacturers are rapidly adapting by introducing DEHP-free and phthalate-free alternatives. These advanced formulations retain the mechanical advantages of PVC while aligning with the Kingdom’s increasing emphasis on sustainability, patient safety, and environmental responsibility. This transition is enabling the PVC segment to retain its growth momentum while also positioning itself as a future-compliant material category in a market that is becoming increasingly quality- and safety-conscious.

Download Free Sample Report

Regional Insights

Northern and Central emerged as the largest market in the Saudi Arabia Blood Bags Market in 2024, holding the largest market share in terms of value. As the capital city and administrative hub, Riyadh plays a pivotal role in driving medical demand in the Central Region. Major public and private hospitals including King Saud Medical City, King Faisal Specialist Hospital & Research Centre, and several military and university-affiliated facilities. National-level blood banks and transfusion centers, which coordinate donor drives and distribute blood products across the Kingdom. The headquarters of the Ministry of Health and SFDA, which often pilot new healthcare programs and allocate national medical budgets from this region. These institutions are not only high-volume consumers of blood bags due to their size and complexity but also set procurement standards that ripple throughout the healthcare ecosystem.

The Central and Northern regions report higher surgical loads and chronic disease burdens, leading to elevated demand for routine and emergency transfusions. A dense urban population, which increases exposure to trauma cases and traffic-related emergencies key drivers of transfusion need. A concentration of specialized healthcare services, such as oncology, hematology, nephrology, and cardiovascular units, that require blood component therapy. A greater number of elective surgeries, transplant operations, and maternal care cases, which often involve pre- and post-operative transfusions. These clinical needs directly translate into a consistently high turnover of blood bags, particularly triple and quadruple configurations used for blood component separation.   

Key Market Players

• Terumo Middle East
• Fresenius Kabi
• Madac International for Medical Products Factory
• RENOLIT
• Abdulla Fouad Group
• Kiefel Technologies
• AdvaCare Pharma
• Jamjoom Group

Report Scope:

In this report, the Saudi Arabia Blood Bags Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Saudi Arabia Blood Bags Market, By Product Type:

o   Single Blood Bag

o   Double Blood Bag

o   Triple Blood Bag

o   Quadruple Blood Bag

o   Penta Blood Bag

• Saudi Arabia Blood Bags Market, By Type:

o   Collection Bag

o   Transfer Bag

• Saudi Arabia Blood Bags Market, By Volume:

o   100ml

o   150ml

o   250ml

o   300ml

o   350ml

o   400ml

o   450ml

o   500ml

• Saudi Arabia Blood Bags Market, By Material:

o   PVC

o   PET

o   Others

• Saudi Arabia Blood Bags Market, By End User:

o   Hospitals & Clinics

o   Ambulatory Surgical Centre

o   Blood Banks

o   Others

• Saudi Arabia Blood Bags Market, By Region:

o   Northern & Central

o   Southern

o   Eastern

o   Western

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Saudi Arabia Blood Bags Market.

Available Customizations:

Saudi Arabia Blood Bags market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).